Is age a negative prognostic indicator in HIV infection or AIDS?

Marla J. Keller, J. M. Hausdorff, L. Kyne, J. Y. Wei

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

To better understand disease progression in older persons with human immunodeficiency virus (HIV infection or acquired immunodeficiency syndrome (AIDS), we studied patients aged 50 years and older hospitalized with a diagnosis of HIV infection or AIDS between January 1985 and October 1995. Data collected included demographics, opportunistic infections, comorbid disease, neurologic dysfunction, and antiretroviral therapy. A total of 86 patients with a mean age of 54.3 years was identified. Pneumocystis carinii pneumonia was the most frequent opportunistic infection (43%). Hypertension was the most common previous medical condition (38%). Other comorbid disease was present in less than 15% of the subjects. Fifty-seven patients (66%) had neurologic impairment, with 30 requiring treatment for delirium. In these 30, 23 (77%) had anemia, infection, or both. The median length of survival following the diagnosis of AIDS was 18.5 months, for HIV it was 48 months. The median survival following the diagnosis of AIDS in patients who received antiretroviral therapy was 22 months compared with 11 months for those who did not receive antiretroviral therapy (p<0.0004). Multivariable analysis found that antiretroviral therapy was the only independent predictor of survival after the diagnosis of AIDS. In contrast to previous studies, the present findings suggest that older age may not necessarily be associated with more rapid disease progression and reduced survival times in persons with HIV infection or AIDS. In those patients with delirium, many may have readily treatable conditions (anemia and/or infection). The absence of significant comorbid disease and the access to antiretroviral therapy may be in part responsible for the longer survival times obtained in this cohort compared to that reported previously.

Original languageEnglish (US)
Pages (from-to)35-38
Number of pages4
JournalAging clinical and experimental research
Volume11
Issue number1
StatePublished - Feb 1999
Externally publishedYes

Fingerprint

HIV Infections
Acquired Immunodeficiency Syndrome
Survival
Delirium
Opportunistic Infections
Disease Progression
Anemia
Therapeutics
HIV
Pneumocystis Pneumonia
Virus Diseases
Neurologic Manifestations
Infection
Nervous System
Demography
Hypertension

Keywords

  • AIDS
  • Elderly
  • HIV
  • Survival

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Is age a negative prognostic indicator in HIV infection or AIDS? / Keller, Marla J.; Hausdorff, J. M.; Kyne, L.; Wei, J. Y.

In: Aging clinical and experimental research, Vol. 11, No. 1, 02.1999, p. 35-38.

Research output: Contribution to journalArticle

Keller, Marla J. ; Hausdorff, J. M. ; Kyne, L. ; Wei, J. Y. / Is age a negative prognostic indicator in HIV infection or AIDS?. In: Aging clinical and experimental research. 1999 ; Vol. 11, No. 1. pp. 35-38.
@article{6aea2e8d87ed460c9c5209237a476d12,
title = "Is age a negative prognostic indicator in HIV infection or AIDS?",
abstract = "To better understand disease progression in older persons with human immunodeficiency virus (HIV infection or acquired immunodeficiency syndrome (AIDS), we studied patients aged 50 years and older hospitalized with a diagnosis of HIV infection or AIDS between January 1985 and October 1995. Data collected included demographics, opportunistic infections, comorbid disease, neurologic dysfunction, and antiretroviral therapy. A total of 86 patients with a mean age of 54.3 years was identified. Pneumocystis carinii pneumonia was the most frequent opportunistic infection (43{\%}). Hypertension was the most common previous medical condition (38{\%}). Other comorbid disease was present in less than 15{\%} of the subjects. Fifty-seven patients (66{\%}) had neurologic impairment, with 30 requiring treatment for delirium. In these 30, 23 (77{\%}) had anemia, infection, or both. The median length of survival following the diagnosis of AIDS was 18.5 months, for HIV it was 48 months. The median survival following the diagnosis of AIDS in patients who received antiretroviral therapy was 22 months compared with 11 months for those who did not receive antiretroviral therapy (p<0.0004). Multivariable analysis found that antiretroviral therapy was the only independent predictor of survival after the diagnosis of AIDS. In contrast to previous studies, the present findings suggest that older age may not necessarily be associated with more rapid disease progression and reduced survival times in persons with HIV infection or AIDS. In those patients with delirium, many may have readily treatable conditions (anemia and/or infection). The absence of significant comorbid disease and the access to antiretroviral therapy may be in part responsible for the longer survival times obtained in this cohort compared to that reported previously.",
keywords = "AIDS, Elderly, HIV, Survival",
author = "Keller, {Marla J.} and Hausdorff, {J. M.} and L. Kyne and Wei, {J. Y.}",
year = "1999",
month = "2",
language = "English (US)",
volume = "11",
pages = "35--38",
journal = "Aging",
issn = "1594-0667",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Is age a negative prognostic indicator in HIV infection or AIDS?

AU - Keller, Marla J.

AU - Hausdorff, J. M.

AU - Kyne, L.

AU - Wei, J. Y.

PY - 1999/2

Y1 - 1999/2

N2 - To better understand disease progression in older persons with human immunodeficiency virus (HIV infection or acquired immunodeficiency syndrome (AIDS), we studied patients aged 50 years and older hospitalized with a diagnosis of HIV infection or AIDS between January 1985 and October 1995. Data collected included demographics, opportunistic infections, comorbid disease, neurologic dysfunction, and antiretroviral therapy. A total of 86 patients with a mean age of 54.3 years was identified. Pneumocystis carinii pneumonia was the most frequent opportunistic infection (43%). Hypertension was the most common previous medical condition (38%). Other comorbid disease was present in less than 15% of the subjects. Fifty-seven patients (66%) had neurologic impairment, with 30 requiring treatment for delirium. In these 30, 23 (77%) had anemia, infection, or both. The median length of survival following the diagnosis of AIDS was 18.5 months, for HIV it was 48 months. The median survival following the diagnosis of AIDS in patients who received antiretroviral therapy was 22 months compared with 11 months for those who did not receive antiretroviral therapy (p<0.0004). Multivariable analysis found that antiretroviral therapy was the only independent predictor of survival after the diagnosis of AIDS. In contrast to previous studies, the present findings suggest that older age may not necessarily be associated with more rapid disease progression and reduced survival times in persons with HIV infection or AIDS. In those patients with delirium, many may have readily treatable conditions (anemia and/or infection). The absence of significant comorbid disease and the access to antiretroviral therapy may be in part responsible for the longer survival times obtained in this cohort compared to that reported previously.

AB - To better understand disease progression in older persons with human immunodeficiency virus (HIV infection or acquired immunodeficiency syndrome (AIDS), we studied patients aged 50 years and older hospitalized with a diagnosis of HIV infection or AIDS between January 1985 and October 1995. Data collected included demographics, opportunistic infections, comorbid disease, neurologic dysfunction, and antiretroviral therapy. A total of 86 patients with a mean age of 54.3 years was identified. Pneumocystis carinii pneumonia was the most frequent opportunistic infection (43%). Hypertension was the most common previous medical condition (38%). Other comorbid disease was present in less than 15% of the subjects. Fifty-seven patients (66%) had neurologic impairment, with 30 requiring treatment for delirium. In these 30, 23 (77%) had anemia, infection, or both. The median length of survival following the diagnosis of AIDS was 18.5 months, for HIV it was 48 months. The median survival following the diagnosis of AIDS in patients who received antiretroviral therapy was 22 months compared with 11 months for those who did not receive antiretroviral therapy (p<0.0004). Multivariable analysis found that antiretroviral therapy was the only independent predictor of survival after the diagnosis of AIDS. In contrast to previous studies, the present findings suggest that older age may not necessarily be associated with more rapid disease progression and reduced survival times in persons with HIV infection or AIDS. In those patients with delirium, many may have readily treatable conditions (anemia and/or infection). The absence of significant comorbid disease and the access to antiretroviral therapy may be in part responsible for the longer survival times obtained in this cohort compared to that reported previously.

KW - AIDS

KW - Elderly

KW - HIV

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0032959020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032959020&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 35

EP - 38

JO - Aging

JF - Aging

SN - 1594-0667

IS - 1

ER -